CERC Stock Price, News & Analysis

CERC

Company Description

CERC (Nasdaq: CERC) is a publicly traded company.

CERC stock has gained 11.8% over the past year.

This page provides a comprehensive overview of CERC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+11.83%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

CERC (CERC) stock. Over the past 12 months, the stock has gained 11.8%.

Latest News

View All

August 26, 2021

0.00%

Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.

August 2, 2021

0.00%

Cerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates

earnings

August 2, 2021

+1.13%

Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance

July 26, 2021

-1.08%

Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients

clinical trial

June 23, 2021

+4.29%

Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets

June 7, 2021

+12.07%

Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance

CERC has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, clinical trial, conferences, fda approval, covid-19. View all CERC news →

SEC Filings

View All

No SEC filings available for CERC.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months